Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000041

Chief Medical Officer returned 3,002 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Podnos Yale Chief Medical Officer 2024-11-20 Returned to the company −1,709 $0.14 $232 74,261 D: show line 1 in the form
Podnos Yale Chief Medical Officer 2024-11-20 Returned to the company −267 $0.14 $36 73,994 D: show line 2 in the form
Podnos Yale Chief Medical Officer 2024-11-20 Returned to the company −1,026 $0.14 $140 72,968 D: show line 3 in the form
Loading xslF345X05/wk-form4_1732231216.xml…